Antitumor effects of bevacizumab in a microenvironment-dependent human adult T-cell leukemia/lymphoma mouse model.
Mori F, Ishida T, Ito A, Sato F, Masaki A, Narita T, Suzuki S, Yamada T, Takino H, Ri M, Kusumoto S, Komatsu H, Hishizawa M, Imada K, Takaori-Kondo A, Niimi A, Ueda R, Inagaki H, Iida S.
Mori F, et al. Among authors: kusumoto s.
Eur J Haematol. 2014 Mar;92(3):219-28. doi: 10.1111/ejh.12231. Epub 2013 Nov 26.
Eur J Haematol. 2014.
PMID: 24188416